Skip to main content

Panagora Asset Management Inc

Source: SEC Form 13F · as of Mar 2026

Panagora Asset Management Inc holds 43 biotech & pharma companies tracked by BioSniper, totaling $624.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

43

Total value held

$624.0M

BioSniper AIPage evidence connected

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.1,165,376$162.4M
INCYIncyte Corp.1,210,909$114.0M
REGNREGENERON PHARMACEUTICALS, INC.105,225$81.3M
BBIOBridgeBio Pharma, Inc.742,117$55.1M
ARWRARROWHEAD PHARMACEUTICALS, INC.461,193$28.9M
JAZZJazz Pharmaceuticals plc143,499$27.1M
PTCTPTC THERAPEUTICS, INC.351,370$23.9M
TVTXTravere Therapeutics, Inc.592,912$17.6M
ONCBeOne Medicines Ltd.57,320$17.0M
ACADACADIA PHARMACEUTICALS INC688,649$15.3M
PTGXProtagonist Therapeutics, Inc116,609$12.3M
RLAYRelay Therapeutics, Inc.818,041$8.1M
AGIOAGIOS PHARMACEUTICALS, INC.238,468$8.1M
ADPTAdaptive Biotechnologies Corp515,926$7.2M
VRDNViridian Therapeutics, Inc.\DE313,700$6.1M
ZYMEZymeworks Inc.206,854$5.2M
CLDXCelldex Therapeutics, Inc.142,327$4.5M
IONSIONIS PHARMACEUTICALS INC57,446$4.3M
ALNYALNYLAM PHARMACEUTICALS, INC.10,343$3.4M
HROWHARROW, INC.86,097$3.0M
CHRSCoherus Oncology, Inc.1,459,310$2.5M
MRNAModerna, Inc.42,525$2.2M
XOMAXOMA Royalty Corporation58,662$1.8M
ALECAlector, Inc.590,388$1.3M
PBYIPUMA BIOTECHNOLOGY, INC.194,887$1.2M
KODKodiak Sciences Inc.29,717$1.1M
KALVKalVista Pharmaceuticals, Inc.50,792$1.0M
ABEOABEONA THERAPEUTICS INC.199,145$892K
RGNXREGENXBIO Inc.102,140$856K
OCULOCULAR THERAPEUTIX, INC94,530$801K
HRTXHERON THERAPEUTICS, INC. /DE/962,505$770K
SLDBSolid Biosciences Inc.91,095$656K
XERSXeris Biopharma Holdings, Inc.104,744$608K
AGENAGENUS INC163,148$545K
GERNGERON CORP360,845$538K
FDMT4D Molecular Therapeutics, Inc.47,328$441K
TEVATeva Pharmaceutical Industries Limited13,550$408K
KROSKeros Therapeutics, Inc.34,656$383K
ZNTLZentalis Pharmaceuticals, Inc.139,690$327K
EXELEXELIXIS, INC.6,640$285K
CCCCC4 Therapeutics, Inc.86,760$228K
RZLTRezolute, Inc.16,385$50K
JSPRJasper Therapeutics Inc.21,543$19K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.